517 related articles for article (PubMed ID: 32310723)
1. Micelles: Promising Ocular Drug Carriers for Anterior and Posterior Segment Diseases.
Durgun ME; Güngör S; Özsoy Y
J Ocul Pharmacol Ther; 2020; 36(6):323-341. PubMed ID: 32310723
[TBL] [Abstract][Full Text] [Related]
2. Polymeric micelles for ocular drug delivery: From structural frameworks to recent preclinical studies.
Mandal A; Bisht R; Rupenthal ID; Mitra AK
J Control Release; 2017 Feb; 248():96-116. PubMed ID: 28087407
[TBL] [Abstract][Full Text] [Related]
3. Nanotechnology for Topical Drug Delivery to the Anterior Segment of the Eye.
Vaneev A; Tikhomirova V; Chesnokova N; Popova E; Beznos O; Kost O; Klyachko N
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830247
[TBL] [Abstract][Full Text] [Related]
4. Drug delivery to the posterior segment of the eye.
Fischer N; Narayanan R; Loewenstein A; Kuppermann BD
Eur J Ophthalmol; 2011; 21 Suppl 6():S20-6. PubMed ID: 23264325
[TBL] [Abstract][Full Text] [Related]
5. Advances in ocular drug delivery.
Rawas-Qalaji M; Williams CA
Curr Eye Res; 2012 May; 37(5):345-56. PubMed ID: 22510004
[TBL] [Abstract][Full Text] [Related]
6. Novel Ocular Drug Delivery Systems: An Update on Microemulsions.
Üstündağ Okur N; Çağlar EŞ; Siafaka PI
J Ocul Pharmacol Ther; 2020; 36(6):342-354. PubMed ID: 32255728
[TBL] [Abstract][Full Text] [Related]
7. A review of implantable intravitreal drug delivery technologies for the treatment of posterior segment eye diseases.
Choonara YE; Pillay V; Danckwerts MP; Carmichael TR; du Toit LC
J Pharm Sci; 2010 May; 99(5):2219-39. PubMed ID: 19894268
[TBL] [Abstract][Full Text] [Related]
8. Challenges and opportunities for drug delivery to the posterior of the eye.
Cabrera FJ; Wang DC; Reddy K; Acharya G; Shin CS
Drug Discov Today; 2019 Aug; 24(8):1679-1684. PubMed ID: 31175955
[TBL] [Abstract][Full Text] [Related]
9. Current and future ophthalmic drug delivery systems. A shift to the posterior segment.
Del Amo EM; Urtti A
Drug Discov Today; 2008 Feb; 13(3-4):135-43. PubMed ID: 18275911
[TBL] [Abstract][Full Text] [Related]
10. Recent advances in ocular drug delivery.
Achouri D; Alhanout K; Piccerelle P; Andrieu V
Drug Dev Ind Pharm; 2013 Nov; 39(11):1599-617. PubMed ID: 23153114
[TBL] [Abstract][Full Text] [Related]
11. Recent patents on ocular drug delivery systems.
Conway BR
Recent Pat Drug Deliv Formul; 2008; 2(1):1-8. PubMed ID: 19075892
[TBL] [Abstract][Full Text] [Related]
12. Ocular Drug Delivery - New Strategies for Targeting Anterior and Posterior Segments of the Eye.
Fangueiro JF; Veiga F; Silva AM; Souto EB
Curr Pharm Des; 2016; 22(9):1135-46. PubMed ID: 26675225
[TBL] [Abstract][Full Text] [Related]
13. Recent progress in ocular drug delivery for posterior segment disease: emphasis on transscleral iontophoresis.
Myles ME; Neumann DM; Hill JM
Adv Drug Deliv Rev; 2005 Dec; 57(14):2063-79. PubMed ID: 16310884
[TBL] [Abstract][Full Text] [Related]
14. Nanoparticles for drug delivery to the anterior segment of the eye.
Janagam DR; Wu L; Lowe TL
Adv Drug Deliv Rev; 2017 Dec; 122():31-64. PubMed ID: 28392306
[TBL] [Abstract][Full Text] [Related]
15. Controlled and continuous release ocular drug delivery systems: pros and cons.
Abdelkader H; Alany RG
Curr Drug Deliv; 2012 Jul; 9(4):421-30. PubMed ID: 22640036
[TBL] [Abstract][Full Text] [Related]
16. Minimally invasive microneedles for ocular drug delivery.
Thakur Singh RR; Tekko I; McAvoy K; McMillan H; Jones D; Donnelly RF
Expert Opin Drug Deliv; 2017 Apr; 14(4):525-537. PubMed ID: 27485251
[TBL] [Abstract][Full Text] [Related]
17. Depot formulations to sustain periocular drug delivery to the posterior eye segment.
Agban Y; Thakur SS; Mugisho OO; Rupenthal ID
Drug Discov Today; 2019 Aug; 24(8):1458-1469. PubMed ID: 30930148
[TBL] [Abstract][Full Text] [Related]
18. New micelle myricetin formulation for ocular delivery: improved stability, solubility, and ocular anti-inflammatory treatment.
Sun F; Zheng Z; Lan J; Li X; Li M; Song K; Wu X
Drug Deliv; 2019 Dec; 26(1):575-585. PubMed ID: 31172843
[TBL] [Abstract][Full Text] [Related]
19. Nanotherapy for posterior eye diseases.
Kaur IP; Kakkar S
J Control Release; 2014 Nov; 193():100-12. PubMed ID: 24862316
[TBL] [Abstract][Full Text] [Related]
20. Applications of Nanotechnology-mediated Herbal Nanosystems for Ophthalmic Drug.
Shree D; Patra CN; Sahoo BM
Pharm Nanotechnol; 2024; 12(3):229-250. PubMed ID: 37587812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
